OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Constructing a nanocage-based universal carrier for delivering TLR-activating nucleic acids to enhance antitumor immunotherapy
Baoli Zhang, Xuehui Chen, Guoheng Tang, et al.
Nano Today (2022) Vol. 46, pp. 101564-101564
Closed Access | Times Cited: 23

Showing 23 citing articles:

Self-Adaptive Nanomaterials for Rational Drug Delivery in Cancer Therapy
Guanqing Yang, Yang Liu, Jinjin Chen, et al.
Accounts of Materials Research (2022) Vol. 3, Iss. 12, pp. 1232-1247
Closed Access | Times Cited: 71

Emerging nanoparticle platforms for CpG oligonucleotide delivery
Mingqiang Li, Haochen Yao, Ke Yi, et al.
Biomaterials Science (2024) Vol. 12, Iss. 9, pp. 2203-2228
Closed Access | Times Cited: 9

Bioengineered nanotechnology for nucleic acid delivery
Yang Zhang, Jing Luo, Xiran Gui, et al.
Journal of Controlled Release (2023) Vol. 364, pp. 124-141
Open Access | Times Cited: 20

Ferritin nanocages: a versatile platform for nanozyme design
Chunyu Wang, Qiqi Liu, Xinglu Huang, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 19, pp. 4153-4170
Closed Access | Times Cited: 19

Ferritin in cancer therapy: A pleiotropic tumoraffin nanocage‐based transport
Guodong Deng, Yang Li, Ning Liang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11570-11588
Open Access | Times Cited: 18

Protein-based delivery systems for RNA delivery
Haichao Zhu, Hong Luo, Ruilong Chang, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 253-274
Closed Access | Times Cited: 15

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
Xiaochun Bian, Liping Zhou, Zhiwei Luo, et al.
ACS Nano (2025)
Closed Access

Design and application of ferritin-based nanomedicine for targeted cancer therapy
Baoli Zhang, Kelong Fan
Nanomedicine (2025), pp. 1-20
Closed Access

Bioengineered protein nanocarrier facilitating siRNA escape from lysosomes for targeted RNAi therapy in glioblastoma
Yiliang Jin, Baoli Zhang, Jianru Li, et al.
Science Advances (2025) Vol. 11, Iss. 8
Closed Access

Co-encapsulated Ce6 + CpG and biopeptide-modified liposomes for enhanced transdermal photo-immunotherapy of superficial tumors
Shaozhen Wang, Yang Chen, Yuanyuan Zhang, et al.
Materials Today Bio (2025), pp. 101669-101669
Open Access

Vaccination of TLR7/8 Agonist‐Conjugated Antigen Nanoparticles for Cancer Immunotherapy
Ning Wang, Guiqiang Zhang, Peiyu Zhang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 22
Closed Access | Times Cited: 14

Ferritin-based nanomedicine for disease treatment
Yuanjun Zhu, Yuefeng Zhu, Tianmiao Cao, et al.
Medical Review (2023) Vol. 3, Iss. 1, pp. 49-74
Open Access | Times Cited: 12

The recent advancements in protein nanoparticles for immunotherapy
Miaomiao Xu, Siyuan Wei, Lifan Duan, et al.
Nanoscale (2024) Vol. 16, Iss. 25, pp. 11825-11848
Closed Access | Times Cited: 3

Immunogenic cell death effects induced by doxorubicin improved chemo-immunotherapy via restoration of granzyme B activity
Tao Huang, Xiaofan Sun, Yingqiu Qi, et al.
Nano Research (2023) Vol. 16, Iss. 12, pp. 13250-13258
Closed Access | Times Cited: 8

Nanodelivery Systems as a Novel Strategy to Overcome Treatment Failure of Cancer
He Shi, Xinyu Gou, Shuheng Zhang, et al.
Small Methods (2023) Vol. 8, Iss. 1
Closed Access | Times Cited: 8

Revival of Bioengineered Proteins as Carriers for Nucleic Acids
David C. Scherer, Michael Burger, Jean‐Christophe Leroux
Bioconjugate Chemistry (2024) Vol. 35, Iss. 5, pp. 561-566
Open Access | Times Cited: 2

Integration of Protein Nanocage with CpG Motifs: A Virus‐Mimicked Core‐Shell Nanostructure to Ignite Antitumor Immunity
Qiang Zhang, Junchen Dong, Jiaping Wang, et al.
Small (2023) Vol. 19, Iss. 40
Closed Access | Times Cited: 5

Proton-Gradient-Driven Porphyrin-Based Liposome Remote-Loaded with Imiquimod as In Situ Nanoadjuvants for Synergistically Augmented Tumor Photoimmunotherapy
Dechun Liu, Luyao Fu, Linlin Gong, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 7, pp. 8403-8416
Closed Access | Times Cited: 1

Engineered protein cages with enhanced extracellular drug release for elevated antitumor efficacy
Wen Duan Yan, Hanlin Li, Jiamin Ning, et al.
International Journal of Biological Macromolecules (2024) Vol. 267, pp. 131492-131492
Closed Access | Times Cited: 1

Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment
Wenlu Yan, Ying Cao, Qi Yin, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1028-1028
Open Access

Pharmaceutical Strategies for Optimized mRNA Expression
Yingying Shi, J. Mao, Sijie Wang, et al.
Biomaterials (2024) Vol. 314, pp. 122853-122853
Closed Access

Genetically Engineered Protein Nano-carriers: Viral Capsids and Cage Proteins
Senem Şen, Ali Semerci, Melis Karaca, et al.
Royal Society of Chemistry eBooks (2024), pp. 327-352
Closed Access

Page 1

Scroll to top